Literature DB >> 15133077

Similar genotypes of Pneumocystis jirovecii in different forms of Pneumocystis infection.

Anne Totet1, Hyacinthe Duwat1, Eline Magois1, Vincent Jounieaux1, Patricia Roux2, Christian Raccurt1, Gilles Nevez1.   

Abstract

This study describes the genotyping of Pneumocystis jirovecii organisms isolated from three groups of patients that developed diverse forms of P. jirovecii infection; the patients were monitored in the same French hospital. Forty archival specimens from 13 adults with Pneumocystis pneumonia, eight adults colonized by P. jirovecii and 19 immunocompetent infants infected with the fungus contemporaneously with a bronchiolitis episode were analysed retrospectively. Genotyping was performed by analysis of sequences of the internal transcribed spacer (ITS)1 and ITS2 regions, and of the dihydropteroate synthase (DHPS) locus. At the ITS regions, a high diversity of genotypes, identical main genotypes (B(1)a(3) and B(2)a(1)) and the occurrence of mixed infections (more than one genotype) were observed in the three patient groups. At the DHPS locus, the results indicated the presence of mutants in the two adult groups, as well as in the infant group. Consequently, at these two independent genomic regions, P. jirovecii isolates from patients who developed different forms of infection and who lived in the same geographical region presented common characteristics. These results suggest that patients infected with P. jirovecii, whatever the form of infection they present, are part of a common human reservoir for P. jirovecii.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15133077     DOI: 10.1099/mic.0.26919-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  6 in total

1.  Crystallographic analysis reveals a novel second binding site for trimethoprim in active site double mutants of human dihydrofolate reductase.

Authors:  Vivian Cody; Jim Pace; Jennifer Piraino; Sherry F Queener
Journal:  J Struct Biol       Date:  2011-06-13       Impact factor: 2.867

2.  Kinetic and structural analysis for potent antifolate inhibition of Pneumocystis jirovecii, Pneumocystis carinii, and human dihydrofolate reductases and their active-site variants.

Authors:  Vivian Cody; Jim Pace; Sherry F Queener; Ona O Adair; Aleem Gangjee
Journal:  Antimicrob Agents Chemother       Date:  2013-04-01       Impact factor: 5.191

3.  Prospective multicenter study of Pneumocystis jirovecii colonization among cystic fibrosis patients in France.

Authors:  Francisca Hernández-Hernández; Emilie Fréalle; Patrick Caneiro; Julia Salleron; Isabelle Durand-Joly; Isabelle Accoceberry; Jean-Philippe Bouchara; Benoit Wallaert; Eduardo Dei-Cas; Laurence Delhaes
Journal:  J Clin Microbiol       Date:  2012-09-26       Impact factor: 5.948

4.  Pneumocystis jirovecii Rtt109, a novel drug target for Pneumocystis pneumonia in immunosuppressed humans.

Authors:  Jayme L Dahlin; Theodore Kottom; Junhong Han; Hui Zhou; Michael A Walters; Zhiguo Zhang; Andrew H Limper
Journal:  Antimicrob Agents Chemother       Date:  2014-04-14       Impact factor: 5.191

5.  Atypical Pneumocystis jiroveci pneumonia with multiple nodular granulomas after rituximab for refractory nephrotic syndrome.

Authors:  Mai Sato; Shuichi Ito; Masao Ogura; Koichi Kamei; Isao Miyairi; Ippei Miyata; Masataka Higuchi; Kentaro Matsuoka
Journal:  Pediatr Nephrol       Date:  2012-09-05       Impact factor: 3.714

6.  Correlations of inhibitor kinetics for Pneumocystis jirovecii and human dihydrofolate reductase with structural data for human active site mutant enzyme complexes.

Authors:  Vivian Cody; Jim Pace; Jennifer Makin; Jennifer Piraino; Sherry F Queener; Andre Rosowsky
Journal:  Biochemistry       Date:  2009-03-03       Impact factor: 3.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.